Assessment of Dianhydrogalactitol in the Treatment of Relapsed or Refractory Non-Small Cell Lung Cancer

被引：0
|
作者：
Steino, Anne [1 ]
He, Guangan [2 ]
Zhai, Beibei [3 ]
Bacha, Jeffrey [1 ]
Lu, Shun [4 ]
Brown, Dennis [5 ]
Daugaard, Mads [3 ]
Siddik, Zahid [2 ]
机构：
[1] Delmar Pharmaceut Inc, Vancouver, BC, Canada
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ British Columbia, Vancouver Prostate Ctr, Urol Sci, Vancouver, BC, Canada
[4] Shanghai Lung Canc Ctr, Shanghai, Peoples R China
[5] Delmar Pharmaceut Inc, Menlo Pk, CA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
NSCLC; alkylating agent; drug resistance; dianhydrogalactitol;
D O I：
10.1016/j.jtho.2016.11.1802
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.02c-007
引用
收藏
页码：S1275 / S1276
页数：2
相关论文
共 50 条
  • [1] Post-Market Clinical Trial of Dianhydrogalactitol in the Treatment of Relapsed or Refractory Non-Small Cell Lung Cancer
    Steino, Anne
    He, Guangan
    Bacha, Jeffrey A.
    Kanekal, Sarath
    Brown, Dennis M.
    Santos, Nancy D.
    Chen, Ming
    Siddik, Zahid
    Shun, Lu
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S550 - S550
  • [2] Erlotinib for the treatment of relapsed non-small cell lung cancer
    McLeod, C.
    Bagust, A.
    Boland, A.
    Hockenhull, J.
    Dundar, Y.
    Proudlove, C.
    Davis, H.
    Green, J.
    Macbeth, F.
    Stevenson, J.
    Walley, T.
    Dickson, R.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 41 - 47
  • [3] In vitro activity of dianhydrogalactitol alone or with platinum drugs in the treatment of non-small cell lung cancer
    Steino, Anne
    He, Guangan
    Bacha, Jeffrey A.
    Kanekal, Sarath
    Brown, Dennis M.
    Siddik, Zahid H.
    [J]. CANCER RESEARCH, 2015, 75
  • [4] DIANHYDROGALACTITOL (DAG) VS POLYCHEMOTHERAPY IN NON-SMALL CELL LUNG-CANCER
    EAGAN, RT
    FRYTAK, S
    RUBIN, J
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 21 - 21
  • [5] Phase II Study of Weekly Amrubicin for Refractory or Relapsed Non-small Cell Lung Cancer
    Kitagawa, Chiyoe
    Iwasaku, Masahiro
    Kogure, Yoshihito
    Ando, Masahiko
    Yoshioka, Hiroshige
    Nishiyama, Akihiro
    Watanabe, Naoki
    Kunimasa, Kei
    Tsubouchi, Kazuya
    Oka, Saori
    Saka, Hideo
    [J]. IN VIVO, 2019, 33 (01): : 163 - 166
  • [6] Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer
    Takigawa, N
    Segawa, Y
    Ueoka, H
    Kiura, K
    Tabata, M
    Shibayama, T
    Takata, I
    Miyamoto, H
    Eguchi, K
    Harada, M
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 46 (04) : 272 - 278
  • [7] Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer
    Nagio Takigawa
    Yoshihiko Segawa
    Hiroshi Ueoka
    Katsuyuki Kiura
    Masahiro Tabata
    Takuo Shibayama
    Ichiro Takata
    Hiroaki Miyamoto
    Kenji Eguchi
    Mine Harada
    [J]. Cancer Chemotherapy and Pharmacology, 2000, 46 : 272 - 278
  • [8] Treatment of non-small cell lung cancer
    Reinmuth, N.
    Heigener, D.
    Reck, M.
    [J]. INTERNIST, 2011, 52 (12): : 1414 - 1421
  • [9] PHASE II STUDY OF WEEKLY AMRUBICIN IN PATIENTS WITH REFRACTORY OR RELAPSED NON-SMALL CELL LUNG CANCER
    Iwasaku, Masahiro
    Nishiyama, Akihiro
    Watanabe, Naoki
    Kunimasa, Kei
    Tsubouchi, Kazuya
    Oka, Saori
    Yoshioka, Hiroshige
    Kitagawa, Chiyoe
    Saka, Hideo
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S875 - S875
  • [10] Salvage Fast Neutron Radiotherapy for Treatment of Refractory Non-small Cell Lung Cancer
    Chen, G. G.
    Kollar, L.
    Paximadis, P.
    Joiner, M.
    Burmeister, J.
    Gadgeel, S. M.
    Wozniak, A. J.
    Baciewicz, F.
    Konski, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S504 - S505
12345